# Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia

> **NCT04446052** · PHASE3 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 362 (actual)

## Conditions studied

- Adult Patients (Over 55) With Acute Non-Lymphocytic Leukemia

## Interventions

- **DRUG:** GM-CSF priming
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04446052
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-05-21
- **Primary completion:** 2002-07-10
- **Final completion:** 2002-07-10
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04446052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04446052, "Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04446052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*